Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Navigant Consulting (NCI) Misses Q4 Earnings Estimates

Published 02/20/2018, 08:57 PM
Updated 07/09/2023, 06:31 AM

Navigant Consulting, Inc. (NYSE:NCI) reported lackluster results for fourth-quarter 2017 with year-over-year decline in adjusted earnings and revenues.

Adjusted earnings were $13.8 million or 29 cents per share compared with $14.7 million or 30 cents per share in the prior-year quarter. Adjusted earnings missed the Zacks Consensus Estimate by 11 cents.

Quarterly Details

GAAP earnings for the reported quarter were $43.1 million or 91 cents per share compared with $13.5 million or 28 cents per share in the year-earlier quarter. The surge was aided by benefits from the newly enacted tax law. GAAP earnings for full-year 2017 were $75 million or $1.55 per share compared with $58.1 million or $1.19 per share in the previous year.

Total revenues for the quarter were $255.4 million compared with $266.1 million in the prior-year period. Revenues before reimbursements (RBR) were $230.7 million compared with $239.7 million in the prior-year period. Decrease in revenues across all business segments resulted in this decline. RBR missed the Zacks Consensus Estimate of $244 million. Revenues for full-year 2017 were $1,032.3 million compared with $1,034.5 million in the previous year.

Adjusted EBITDA was $32.3 million, down from $34.8 million in the prior-year quarter largely due to lower revenues.

Navigant Consulting, Inc. Price, Consensus and EPS Surprise

Segment Performance

RBR for the Healthcare segment — which is one of the biggest revenue generating business of the company — decreased to $89.7 million from $91.7 million in the prior-year quarter. Discrepancies in timing and sequencing when entering long-term contracts with clients have resulted in this decline.

The Energy segment’s RBR decreased year over year to $30.7 million from $31.3 million in the reported quarter. The poor performance of this sector was caused by a decrease in activity from U.S. federal government engagements.

The Disputes, Forensics & Legal Technology (earlier known as Disputes, Investigations & Economics) segment’s RBR fell year over year to $74.6 million from $78.4 million due to decline in processing activities in the legal technology solutions business.

The Financial, Risk & Compliance Advisory segment’s RBR declined year over year to $35.7 million from $38.3 million in the prior-year quarter. This segment was adversely impacted by regulatory uncertainty and the conclusion of some large engagements at the end of the previous year.

Balance Sheet and Cash Flow

As of Dec 31, 2017, Navigant had cash and cash equivalents of about $8.4 million compared with $8.3 million a year ago. Bank debt was $133 million compared with $135 million in the year-ago period. Leverage (bank debt divided by trailing 12-month adjusted EBITDA) was 1.06 as of Dec 31, 2017, compared with 0.95 as of Dec 31, 2016.

For the quarter, net cash provided by operating activities was $70.7 million compared with $54.4 million in the year-ago quarter bringing the total tally for the year to $104.2 million and $110 million, respectively. Free cash flow increased to $24.6 million from $7.9 million in the prior-year quarter. Navigant repurchased shares worth $43.00 million at an average price of $18.52 per share in 2017. Of this, shares of about $15.00 million were repurchased at an average price of $17.89 per share in the fourth-quarter of 2017.

Full-Year 2018 Guidance

The company projects revenues to lie between $1.030 billion and $1.065 billion while RBR is expected to be $940-$975 million. Adjusted EBITDA is expected in the range of $125 million to $137 million while adjusted earnings per share are expected in the band of $1.26-$1.44. Free cash flow is expected to be between $75 million and $90 million.

Zacks Rank & Stocks to Consider

Navigant has a Zacks Rank #4 (Sell). Better-ranked stocks in the industry worth considering include CBIZ, Inc. (NYSE:CBZ) , Exponent, Inc. (NASDAQ:EXPO) and S&P Global Inc. (NYSE:SPGI) each carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

CBIZ has exceeded estimates in three of the trailing four quarters with an average beat of 75.1%.

Exponent has exceeded estimates in three of the trailing four quarters with an average beat of 12.4%.

S&P Global has an expected long-term earnings growth rate of 14.5%. It exceeded estimates in each of the trailing four quarters with an average beat of 12.8%.

Today's Stocks from Zacks' Hottest Strategies

It's hard to believe, even for us at Zacks. But while the market gained +18.8% from 2016 - Q1 2017, our top stock-picking screens have returned +157.0%, +128.0%, +97.8%, +94.7%, and +90.2% respectively.

And this outperformance has not just been a recent phenomenon. Over the years it has been remarkably consistent. From 2000 - Q1 2017, the composite yearly average gain for these strategies has beaten the market more than 11X over. Maybe even more remarkable is the fact that we're willing to share their latest stocks with you without cost or obligation.

See Them Free>>



S&P Global Inc. (SPGI): Free Stock Analysis Report

Navigant Consulting, Inc. (NCI): Free Stock Analysis Report

CBIZ, Inc. (CBZ): Free Stock Analysis Report

Exponent, Inc. (EXPO): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.